ea0056p477 | Diabetes therapy | ECE2018
Yildiz Ismail
, Gen Ramazan
, Batmaz Leyla
, Sezer Kerem
, Akbay Esen
, Yuyucu Karabulut Yasemin
Introduction: Although dipeptidyl peptidase-4 (DPP-4) inhibitores are generally safe and are associated with less side effects compared to other oral antidiabetic medications, they could also be associated with some side effects including skin rash. Herein we report the first case of a type 2 diabetes patient who developed a painfull maculopapular rash induced by linagliptin, a widely used DPP-4 inhibitor.Case presentation: A-54-year old female patient w...